Savient Pharmaceuticals, Inc. (NASDAQ:SVNT)

CAPS Rating: 3 out of 5

A biopharmaceutical company engaged in developing and distributing pharmaceutical products that target unmet medical needs in both niche and broader markets.

Recs

0
Player Avatar nolimit8 (< 20) Submitted: 11/17/2006 10:48:26 AM : Outperform Start Price: $10.23 SVNT Score: -91.92

See it going to $15

Featured Broker Partners


Advertisement